ASCO Conference Showcases Lifestyle-Adapted Immunotherapy and Promising Cancer Vaccines

Adjusting dosing schedules alongside early immunotherapy has improved treatment effectiveness; preliminary phase 1 personalized vaccines demonstrate promising responses against head and neck cancers.